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Scrine phosphorylation of insulin/IGF-I receptors in transfected fibroblasts was analysed by peptide mapping. PMA stimulated the phosphorylation 
of 5 distinct insulin receptor phosphopeptides: asingle major phosphothreonine peptide containing Thr-1348, one major and 3 minor phosphoserine 
peptides. The major insulin-stimulated phosphoscrine peptides were the same as those after PMA. with the exception of 2 minor phosphoserinc 
peptides, PMA stimulated phosphorylation of a single major IGF-I receptor phosphoserine pcptide which was phosphorylated to a lesser extent 
after IGF-I. We conclude that insulin/IGF-I and PMA stimulate phosphorylation of the same sites, but differ in the extents of phosphorylation. 
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1. INTRODUCTION 
The binding of insulin to its receptor stimulates auto- 
phosphorylation and activation of the receptor’s intrin- 
sic tyrosine kinase, an event thought to be essential to 
signal transduction [l]. In intact cells (in situ) [2, lo] and 
in some partially purified preparations (in vitro) [3,4,5], 
insulin-stimulated autophosphorylation on tyrosine 
residues of the P-subunit is followed by serine and 
threonine phosphorylation of the insulin receptor by 
poorly characterised kinase(s). Serineithreonine phos- 
phorylation of the insulin receptor by protein kinase A 
or protein kinase C in response to various agonists 
[6,7,8] attenuates the tyrosine kinase activity of the 
receptor indicating a possible mechanism for modu- 
lating the receptor tyrosine kinase via other signalling 
systems. 
and identify phosphorylation sites [ lO,ll, 121. Insulin 
receptor residue Threonine-1348” (1336) has been 
shown to be a major site of phosphorylation i  response 
to PMA-stimulation in intact cells and protein Kinase C 
in vitro [ 11,131 while insulin-stimulated phosphoryla- 
tion occurs on Serines-1305/1306 (1293/1294) and 
other sites [12]. In the present study, we sought to com- 
pare directly the patterns of serineithreonine phospho- 
rylation of the insulin receptor and IGF-1 receptors in 
response to phorbol ester and insulin or IGF-I using 
two-dimensional tryptic phosphopeptide mapping to 
determine whether there were unique sites associated 
with each agonist, or whether a common pathway 
might mediate the effects of these stimuli. 
2. MATERIALS AND METHODS 
Cell lines that over-express insulin receptor cDNA [9] 
have been utilised in a number of recent studies to in- 
vestigate patterns of insulin receptor phosphorylation 
*Amino acid sequence numbers used are those of Ebina et al. (1986) 
Cell 40, 747, while the corresponding number in the sequence of 
Ullrich et al. (1986) Nature 313, 7% is shown in parenrheses. 
Abiweviations: PMA, 4&phorbol 12&myristate I3n-acetate; SDS- 
PAGE, Sodium Dodecyl sulphate-polyacrylamidegel c ectrophoresis; 
DMSO. Dimethylsulphoxide; IGF-I, insulin-like growth factor I; 
PKC. protein kinase C. 
The NIH-3T3-HIR 3.5 cell line overexpressing human insulin 
receptor cDNA [9] and IGF-I-R/3T3 cell line overexpressing the 
human IGF-1 receptor cDNA [23] were as previously described. 
[“PlOrthophosphate (PBS 41) was obtained from Amersham Inter- 
national, Amersham, Bucks, UK. TPCK-Trypsin (Worthington) was 
from Lorne Laboratories. Cellulose thin layer plates were from 
Eastman-Kodak, Liverpool, UK. Immobilon (PVDF) membranes 
were purchased from Millipore. 4R-phorbol 120.myristatc 13cr- 
acetate (PMA), Protein-A sepbarose CL-4B and N-ethyl morpholiue 
were supplied by Sigma, Poole. Dorset, UK. Organic solvents (Analar 
grade) were purchased from BDH, Poole, Dorset. UK. All other 
reagents used were of the highest grade commercially available. 
Co/resporrdence onrl presenf odc/rcss: T.S, Pi&y, Dcpartmcnt of 
Chemical Pathology, Royal Postgraduate Medical School, Ham- 
mersmith Hospital, Du Cane Road, London, WI2 ONN, UK. Fax: 
(44) (81) 746 1159. 
Metabolic labeling of receptors from intact cells was carried out as 
described [lo] using 2 mCi/ml of [32P]ortllophosphate with subse- 
quent exposure IO insulin, IGF-I or PMA as indicated. Insulin recep- 
tors were immunoprecipitated with antibody 83-14 [14] and IGF-1 
receptors with (ulR3 [24] provided by Dr S. Jacobs as described [IO]. 
Gel electrophoresis was performed on tricine-SDS 7.5% polyacryl- 
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amide gels [lS] and gels were subjected to autoradiography on Kodak 
X-omat XAR film. Incorporation of “P was quantified as described 
1141. 
Peptide mapping of the insulin and IGF-I receptors was performed 
as described [I61 except for the following modifications. Tryptic 
digestion was performed in 100 mM N-ethyl morpholine acetate pH 
8.3. The lyophilised tryptic pkosphopeptides were dissolved in 5 rtl of 
306/o formic acid and spotted onto thin layer plates. High voltage elec- 
trophoresis was performed in 30% formic acid (pH 1.9) in the first 
dimension for 1500 V.h until the DNP-Lysine marker had migrated 
10 ems. Plates were rapidly dried under an air stream and chroma- 
tography performed in the 2nd dimension [16] with isobutanol/acetic 
acid/water/pyridine (90: 18:72:60; oH 3.5). Peptides from thin layer 
cellulose plates were eluted using 30% formic acid, evaporated, 
hydrolysed at 110°C for 1 h and analysed for phosphoamino acids 
]]61. 
3. RESULTS 
Treatment of the NIH-3T3-HIR 3.5 cells with PMA 
caused a dose- and time-dependent increase in insulin 
receptor fl-subunit phosphorylation of up to 3-fold, 
with maximal effects after 30 min at micromolar con- 
centrations of PMA (Fig. la). Similar increases were 
observed in IGF-I receptor phosphorylation in IGF-I- 
R/3T3 cells (Fig. lb). Tryptic phosphopeptide mapping 
of the insulin receptor P-subunit revealed 5 distinct 
phosphopeptides after phorbol ester stimulation (Fig. 
2b). Individual phosphopeptides were analysed for 
phosphoamino acid content (Fig. 3). The major phos- 
phopeptides were a relatively hydrophobic phospho- 
threonine peptide (T) and a hydrophobic phosphoserine 
peptide (Sl). In addition, three other less hydrophobic 
minor labeled tryptic peptides are seen (S2, S3, S4) (Fig. 
2b). In unstimulated (basal) cells, insulin receptor 
phosphopeptides T and Sl (Fig. 2a) were barely detec- 
table in comparison with cells stimulated by PMA. 
Tryptic digestion of P-subunit from insulin-stimu- 
lated cells showed the major tyrosine phosphopeptides 
in addition to the serine and threonine phosphopeptides 
Sl, S2 and T (Fig. 2~). Peptide Sl corn&rated with Y6 
as phosphoamino acid analysis of this spot (Y6/Sl; Fig. 
2c) revealed phosphotyrosine and a small amount of 
phosphoserine (Fig. 3). Peptides S3 and 54 were not 
observed with insulin and appeared to be specific for 
!he phorbol ester-induced phosphorylation. Insulin also 
increased the phosphorylation of phosphopeptide T 
above the basal level but to a lesser extent than that seen 
with PMA. 
In unstimulated IGF-I-R/3T3 cells (Fig. 2d), the 
IGF-I receptor showed 5 phosphopeptides designated 
SI, SII, SIII, SIV and SV. Addition of IGF-I (Fig. 2f) 
to intact cells resulted in the appearance of additional 
%E+ uw- PMA Insulin 
Insulin 
lb) 
IGF-I PMA PMA and 
IGF-I 
Fig. I, NIH-3T3-HlR 3.5 cells (pnnel a) and IGF-I-R/3T3 cells (panel b) were labeled with 32P and exposed to I bM PMA (30 min) and/or I PM 
insulin (NIH-3T3-HIR 3.S cells) (5 min) and 0.1 pM IGF-I (IGF-I-R/3T3 cells) (5 min) as indicated. Insulin or IGF.1 receptors wcrc im- 
munoprccipitated from solubilised cells and analysed by SDS-PAGE (7.5%) and autoradiography. Only the receptor &subunit bands are shown. 
Panel a: insulin receptor from NIH-3T3-HIR 3.5 cells. Paacl b: IGF-I receptor from IGF-I-R/3T3 cells. 
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Fig. 3. Phosphoamino acid analysis of selected insulin receptor phosphopeptides after PMA (panel a) and insulin-stimulation (panel b). The tryptic 
phosphopeptides obtained after phosphorylation f the insulin receptor (Fig. 2b,c) were excised from the thin layer plate, luted into 30% formic 
acid and lyophilised. The pepetides were then hydrolysed in 6 M HCI and the hydrolysates analysed by high voltage electrophoresis at pH 3.5. a2p_ 
phosphoamino acids were located by autoradiography and the unlabeled phosphoamino acids detected byninhydrin staining. The origin lies at 
the cathodal end (bottom). PS, phosphoserine; PT. phosphothreonine; PY, phosphotyrosine. 
major phosphopeptides YI, YIa, YIV, YV, YVI, YIlI 
and minor peptide YVII. Peptides YI, ¥Ia, YIV, YV 
and YVI appeared to be similar to their counterparts 
derived from the insulin receptor. The labeling of SI was 
only modestly increased by iGF-I while the addition of 
PMA resulted in a 2-fold increase in the labeling of SI 
and the appearance of a further minor peptide SVI. 
This was associated with the concomitant disap- 
pearance of peptides Sill, SIV and SV. 
4. DISCUSSION 
Serine/threonine phosphorylation of i sulin and 
IGF-I receptors has been studied previously in several 
cell types [7,10-13,21,22]. However, the sites of phos- 
phorylation i response todifferent stimuli have seldom 
been compared irectly within a single cell type [21]. 
The use of transfected fibroblasts allows such direct 
comparison, and the high level of receptor expression i
these cells facilitates analysis of phosphopeptides. We
modified the conditions for separating tryptic phospho- 
peptides by 2D thin layer methods, compared to 
previous tudies on transfected cells [10-12]. Firstly, by 
not using a preliminary HPLC fractionation step, we 
eliminated the possibility of losing markedly hydropho- 
bic phosphopeptides by failure to elute from reverse- 
phase columns, and we were able to compare the 
mobility and relative labeling of all peptides from a 
given receptor preparation on a single map. Secondly, it
was found that resolution of the major serine/threonine 
phosphopeptides during high voltage electrophoresis 
was significantly improved at pH 1.9 over that at pH 
3.5 [10,16] and consequently additional serine phospho- 
peptides were identified compared with those observed 
previously [!0]. In particular, itwas found that a major 
phosphoserine peptide S I (Fig. 2) comigrated with 
phosphopeptide Y6 [17]. Furthermore, to extend upon 
studies of insulin receptor phosphorylation wereport, 
for the first time, a partial characterization f IGF-I 
and PMA stimulated serine/threonine phosphorylation 
sites of the IGF-I receptor in a transfected cell line, 
IGF-I-R/3T3 [23]. 
In terms of the major sites phosphorylated, insulin- 
and PMA-stimulated phosphorylation of the same pep- 
tides. However, differences were clearly evident in he 
extent of phosphorylation a d the effects of insulin and 
PMA on overall phosphorylation were almost additive 
(Fig. 1). The insulin-stimulated increases in receptor 
serine/threonine phosphorylation may partly be ex- 
plained by a weak activation of PKC [19,20]. The fact 
that peptides $3 and $4 are not seen in insulin-sti- 
mulated cells may be a reflection of the different time 
courses and extent of enzyme activation in response to 
the 2 agonists. However, it is also possible that distinct 
enzymes (PKC isoenzymes or other kinases) are ac- 
tivated in response to PMA and insulin. The increase in 
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labeling of peptide T was greater with PMA than with 
insulin suggesting that this site was relatively more 
specific for protein kinase C and possibly less specific 
for the insulin-stimulated insuhn receptor serine kinase. 
In an immunoaffinity-purified insulin receptor prepara- 
tion that retains serine kinase activity towards the in- 
sulin receptor phosphopeptide T is absent [17]. 
However, studies involving inhibition or downregula- 
tion of PKC in HepG2 cells suggest that PKC is unlikely 
to be significantly involved in insulin-stimulated insulin 
receptor phosphorylation [25]. 
Differences between the pattern of insulin and PMA- 
induced insulin receptor phosphorylations are also seen 
in other cell types. In IM9 and HepG2 ce!ls [21,2.5] a 
hydrophobic phosphothreonine peptide was observed 
in the basal state, whose phosphorylation was 
stimulated by PMA and to a lesser extent by insulin. In 
these cells PMA stimulated the appearance of 4 other 
phosphoserine peptides. Based on synthetic peptide co- 
migration [ 11,131 the appearance of phosphopeptide T 
reflects the phosphorylation of Thr-1348 (1336). In Fao 
rat hepatoma cells [7], PMA and insulin were both 
shown to stimulate the phosphorylation of 9 phospho- 
peptides of which 3 were specific to each stimulus. In 
rat H-35 cells [13] phorbol ester-induced phosphoryla- 
tion of the insulin receptor occurred on a single 
phosphothreonine peptide and 2 phosphoserine pep- 
tides. Although direct comparison with the present 
work is difficult, the phosphoserine peptides appeared 
to correspond to phosphopeptides S3 and S4 although 
they may represent phosphopeptides Sl and S2. 11: is 
unlikely that any of these phosphopeptides reflect 
phosphorylation at serines-130511306 (1293/1294), the 
only eerine phosphorylation site defined to date [12] 
because this phosphopeptide is fairly hydrophilic and 
highly charged at pH 1.9, and consequently would be 
expected to migrate near phosphopeptide Y3. The iden- 
tities of the other phosphorylation sites remain 
unknown. It is not clear whether these additional serine 
phosphopeptides represent distinct sites of phosphoryl- 
ation or are the result of differential tryptic cleavage 
because of contiguous basic residues. 
The major phorbol-ester induced phosphoryIation 
site in the IGF-I receptor is located in a phosphoserine- 
containing peptide SI (Fig. 2e) that has no clear count- 
erpart in the insulin receptor suggesting that this E& 1J 
located in a region that is not or poorly conserved II: tin 
IGF-I receptor. PMA was more effective at increasing 
phosphorylation of this site than IGF-I. There was no 
counterpart to the insulin receptor T peptide in the IGF- 
I receptor. This would be expected as threonine-1348 of 
the insulin receptor is replaced by proline at the equi- 
valent position in the IGF-I receptor. The pattern of 
serine phosphorylation of IGF-I receptor in transfected 
NIH 3T3 cells appeared less complex than previously 
reported in IM9 and HepG2 cells. None of these sites of 
serine phosphorylation has yet been identified. 
210 
It would appear that insulin or IGF-I-stimulated 
serine/threonine phosphorylation would be of fairly 
low stoichiometry compared to tyrosine autophospho- 
rylation in these cells, assuming that 32P equilibrates 
equally at all sites under the conditions used. If this 
were true, then it suggests that functional effects on 
tyrosine kinase activity are unlikely to be of significance 
if on1.y a small proportion of receptors are involved. 
Alternatively, serine/threonine phosphorylation could 
significantly affect a distinct cellular subfraction of 
receptors, eg. influencing subcellular distribution [26]. 
Given the multiple sites involved and the existence of 
multiple PKC isoenzymes [27], it is possible that there 
is an element of tissue specificity in the response to 
phorbol esters affecting either the extent of phospho- 
rylation or specific sites. This would explain the ap- 
parent inhibition of tyrosine kinase activity in some cell 
types [7,8] but not in others [21,22,283. Future studies 
should be directed towards identifying these additional 
sites of serine phosphorylation and assessing their 
relative contributions towards insulin receptor egula- 
tion as well as determining the stoichiometries of in- 
creases in receptor serineithreonine phosphorylation i  
response to insulin, IGF-I and PMA. 
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